Loading clinical trials...
Loading clinical trials...
The purpose of this study is to investigate the value of Orencia in rapidly progressing Rheumatoid Arthritis (RA).
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Bristol-Myers Squibb
NCT07627542 · Rheumatoid Arthritis (RA), Ankylosing Spondylitis (AS), and more
NCT07632872 · Rheumatoid Arthritis (RA), Rheumatoid Arthritis
NCT06733935 · Systemic Sclerosis, Idiopathic Inflammatory Myopathies, and more
NCT07455578 · Autoimmune Diseases, Rheumatoid Arthritis (RA), and more
NCT07171983 · Rheumatoid Arthritis
Local Institution
Beverly Hills, California
Local Institution - 0005
Gainesville, Georgia
Local Institution
Coeur d'Alene, Idaho
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions